Sept. 10, 2024
by Roman Kasianov
News
BIOCAPTIVA, a biotech company based in Edinburgh, has been granted its first US patent for a liquid biopsy technology designed …
Sept. 9, 2024
by Roman Kasianov
News
MGI Tech Co., Ltd., a global developer of life science technologies, has launched two new nanopore sequencing products, CycloneSEQ-WT02 and …
Sept. 9, 2024
by Roman Kasianov
News
Superluminal Medicines, Inc. has raised $120 million in a Series A funding round led by RA Capital Management, with participation …
Sept. 6, 2024
by Andrii Buvailo, PhD
Interview
As the demand for decentralized and hybrid clinical trials rises, Medable Inc. is positioning itself at the forefront of this …
Sept. 6, 2024
by Roman Kasianov
News
Eli Lilly has announced a partnership with Genetic Leap, a biotech company specializing in RNA-targeted drug discovery using AI models. …
Sept. 5, 2024
by Roman Kasianov
News
Neuralink recently captured the public's attention with the implantation of its brain chip in a second patient, allowing the person …
Sept. 4, 2024
by Roman Kasianov
News
Proscia has announced a new real-world data offering on its Concentriq platform, integrating over 10 million de-identified pathology images with …
Sept. 4, 2024
by Roman Kasianov
News
BioAge Labs, a clinical-stage biopharmaceutical company specializing in anti-aging and metabolic disease therapeutics, has filed for an initial public offering …
Sept. 1, 2018
by Andrii Buvailo
Biopharma insight
(Updated: 2.09.2024) Nowadays mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion …
Aug. 29, 2024
by Andrii Buvailo, PhD
News
Noetik, an emerging biotech firm specializing in the application of artificial intelligence (AI) to oncology, has announced the successful closure …
Aug. 29, 2024
by Roman Kasianov
News
Brinter AM Technologies Oy has been selected to provide a 3D bioprinter for a European Space Agency (ESA) project aimed …
Aug. 29, 2024
by Roman Kasianov
News
Novartis has announced that its Phase III V-MONO clinical trial evaluating the small interfering RNA (siRNA) therapy Leqvio (inclisiran) in …